(HYRM) DBX Trust - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US23306X1000 • High Yield Bond

HYRM: High Yield Bonds, USD Cash Positions, Corporate Debt Securities

The DBX ETF Trust (NYSE ARCA: HYRM) is designed to provide exposure to the U.S. dollar-denominated high-yield corporate bond market, incorporating a risk management strategy. The fund seeks to replicate the performance of high-yield bonds during stable market conditions while transitioning to a cash position earning interest at the Effective Federal Funds Rate during periods of market stress. This dual approach aims to balance risk and return, offering a dynamic response to shifting market environments.

The fund adheres to a strict investment policy, allocating at least 80% of its total assets to securities and instruments that replicate the economic characteristics of the index. This includes high-yield corporate bonds, which are typically issued by companies with lower credit ratings, offering higher yields to compensate for increased credit risk. The ETFs structure allows it to maintain flexibility, ensuring alignment with the indexs performance while managing volatility through its adaptive investment strategy.

From a technical perspective, HYRM has shown moderate trading activity, with an average 20-day volume of 2,083 shares. The ETF is currently trading at $23.74, slightly above its 20-day SMA of $23.66 and 50-day SMA of $23.49, but below its 200-day SMA of $22.93. This indicates a recent upward trend but with a longer-term perspective showing a slightly higher valuation. The Average True Range (ATR) of 0.07 reflects low volatility, suggesting stable price movements.

Fundamentally, HYRM manages assets under management (AUM) of $45.69 million, which is relatively modest compared to larger fixed-income ETFs but sufficient to maintain liquidity. The funds focus on high-yield bonds positions it as a higher-risk investment within the fixed-income spectrum, appealing to investors seeking enhanced yields despite the associated credit risks.

3-Month Forecast: - Technical Outlook: The ETFs price is expected to hover around its current range, with potential resistance at $24.00 and support at $23.40. The low ATR suggests minimal price fluctuations. - Fundamental Outlook: With moderate AUM and stable trading volume, HYRM is likely to maintain its current trajectory, with yields remaining attractive for high-yield bond investors.

Additional Sources for HYRM ETF

HYRM ETF Overview

Market Cap in USD 46m
Category High Yield Bond
TER 0.30%
IPO / Inception 2022-02-09

HYRM ETF Ratings

Growth 5y 49.1%
Fundamental -
Dividend 75.1%
Rel. Strength Industry 7.27
Analysts -
Fair Price Momentum 23.51 USD
Fair Price DCF -

HYRM Dividends

Dividend Yield 12m 5.74%
Yield on Cost 5y 6.45%
Annual Growth 5y 11.50%
Payout Consistency 100.0%

HYRM Growth Ratios

Growth Correlation 3m 78.2%
Growth Correlation 12m 96.9%
Growth Correlation 5y 84.9%
CAGR 5y 4.18%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m 0.43
Alpha 2.80
Beta 0.21
Volatility 4.38%
Current Volume 7.4k
Average Volume 20d 2.1k
What is the price of HYRM stocks?
As of March 15, 2025, the stock is trading at USD 23.50 with a total of 7,361 shares traded.
Over the past week, the price has changed by -0.73%, over one month by -0.66%, over three months by +0.60% and over the past year by +8.36%.
Is DBX Trust a good stock to buy?
Partly, yes. Based on ValueRay Analyses, DBX Trust (NYSE ARCA:HYRM) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 49.08 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HYRM as of March 2025 is 23.51. This means that HYRM is currently overvalued and has a potential downside of 0.04%.
Is HYRM a buy, sell or hold?
DBX Trust has no consensus analysts rating.
What are the forecast for HYRM stock price target?
According to ValueRays Forecast Model, HYRM DBX Trust will be worth about 25.6 in March 2026. The stock is currently trading at 23.50. This means that the stock has a potential upside of +8.81%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.6 8.8%